Literature DB >> 22225850

The minimal clinically important difference for the Gait Profile Score.

Richard Baker1, Jennifer L McGinley, Mike Schwartz, Pam Thomason, Jill Rodda, H Kerr Graham.   

Abstract

The minimally clinically important difference (MCID) is an important concept for interpreting the results of clinical research. This paper proposes a rationale for defining an MCID for the Gait Profile Score (GPS) based on an analysis of the difference in median GPS for children classified at different levels of the Functional Assessment Questionnaire. A strong linear correlation between median score and FAQ level was found. An MCID of 1.6° is therefore suggested, reflecting the mean difference between adjacent FAQ levels. Comparison of this value with (i) the standard deviation of GPS from typically developing children (1.4°) and (ii) the percentage of the difference between the median GPS for each FAQ level and that for typically developing children offers further support to suggest that 1.6° is an appropriate figure.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22225850     DOI: 10.1016/j.gaitpost.2011.12.008

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  16 in total

1.  Gait Alteration Due to Haemophilic Arthropathies in Patients with Moderate Haemophilia.

Authors:  Alban Fouasson-Chailloux; Fabien Leboeuf; Yves Maugars; Marc Trossaert; Pierre Menu; François Rannou; Claire Vinatier; Jérome Guicheux; Raphael Gross; Marc Dauty
Journal:  Int J Environ Res Public Health       Date:  2022-06-20       Impact factor: 4.614

2.  Are results after single-event multilevel surgery in cerebral palsy durable?

Authors:  Erich Rutz; Richard Baker; Oren Tirosh; Reinald Brunner
Journal:  Clin Orthop Relat Res       Date:  2013-01-03       Impact factor: 4.176

3.  Associations Between Muscle Synergies and Treatment Outcomes in Cerebral Palsy Are Robust Across Clinical Centers.

Authors:  Benjamin R Shuman; Marije Goudriaan; Kaat Desloovere; Michael H Schwartz; Katherine M Steele
Journal:  Arch Phys Med Rehabil       Date:  2018-04-10       Impact factor: 3.966

4.  Compelled body weight shift approach in rehabilitation of individuals with chronic stroke.

Authors:  Alexander S Aruin; Noel Rao; Asha Sharma; Gouri Chaudhuri
Journal:  Top Stroke Rehabil       Date:  2012 Nov-Dec       Impact factor: 2.119

5.  Dynamic motor control is associated with treatment outcomes for children with cerebral palsy.

Authors:  Michael H Schwartz; Adam Rozumalski; Katherine M Steele
Journal:  Dev Med Child Neurol       Date:  2016-04-21       Impact factor: 5.449

6.  Gait improvement surgery in ambulatory children with diplegic cerebral palsy.

Authors:  Terje Terjesen; Bjørn Lofterød; Ingrid Skaaret
Journal:  Acta Orthop       Date:  2015-01-30       Impact factor: 3.717

7.  Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study.

Authors:  T Hastings-Ison; M Sangeux; P Thomason; B Rawicki; M Fahey; H K Graham
Journal:  J Child Orthop       Date:  2018-08-01       Impact factor: 1.548

8.  An Unsupervised Data-Driven Model to Classify Gait Patterns in Children with Cerebral Palsy.

Authors:  Julie Choisne; Nicolas Fourrier; Geoffrey Handsfield; Nada Signal; Denise Taylor; Nichola Wilson; Susan Stott; Thor F Besier
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

9.  Gait profile score and movement analysis profile in patients with Parkinson's disease during concurrent cognitive load.

Authors:  Danielli S Speciali; Elaine M Oliveira; Jefferson R Cardoso; João C F Correa; Richard Baker; Paulo R G Lucareli
Journal:  Braz J Phys Ther       Date:  2014-07-18       Impact factor: 3.377

10.  Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.

Authors:  Juliette Ropars; Mathieu Lempereur; Carole Vuillerot; Vincent Tiffreau; Sylviane Peudenier; Jean-Marie Cuisset; Yann Pereon; Fabien Leboeuf; Ludovic Delporte; Yannick Delpierre; Raphaël Gross; Sylvain Brochard
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.